...
首页> 外文期刊>Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism >Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
【24h】

Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.

机译:IV型磷酸二酯酶在脑血管中的鉴定,表征和功能作用:选择性磷酸二酯酶抑制剂的作用。

获取原文
获取原文并翻译 | 示例

摘要

The role of the phosphodiesterase type IV isozyme (PDE IV) in the regulation of cerebrovascular tone was investigated in the canine basilar artery in vitro and in vivo. The PDE isozymes extracted from the canine basilar artery were isolated by diethylaminoethanol (DEAE)-Sepharose affinity chromatography and identified based on sensitivity to isozyme-selective PDE inhibitors. [3H]cAMP hydrolysis was observed in one major and one minor peak of activity. The predominant peak was inhibited by the addition of cGMP (25%), siguazodan (26%), rolipram (39%), and the combination of siguazodan and rolipram (95%). Selective PDE IV inhibitors BRL 61063, rolipram, and denbufylline were equieffective inhibitors of [3H]-ccAMP hydrolysis mediated by PDE IV isolated from the canine basilar artery [concentrations producing 50% inhibition (IC50S) = 0.21 +/- 0.05 microM, 0.67 +/- 0.23 microM, and 0.73 +/- 0.16 microM, respectively]. In precontracted isolated ring segments of the canine basilar artery, selective PDE IV inhibitors produced potent and complete relaxation (IC50S < 150 nM). In contrast, zaprinast (a selective PDE V inhibitor) and siguazodan (a selective PDE III inhibitor) produced only weak relaxation of the basilar artery (IC50S = 4.5 microM and > 10 microM, respectively). Vasorelaxation produced by PDE IV inhibitors was not altered by removing the endothelium, 1-NAME, or adenosine receptor antagonism. In a canine model of acute cerebral vasospasm, all three selective PDE IV inhibitors reversed basilar artery spasm produced by autologous blood without altering mean arterial blood pressure. In contrast, prolonged treatment with BRL 61063 failed to alter the development of basilar spasm in the two hemorrhage canine models of chronic cerebral vasospasm. Denbufylline-induced relaxation in vitro was also significantly impaired in basilar arteries obtained from the model of chronic vasospasm. In conclusion, PDE IV appears to be the predominant isozyme regulating vascular tone mediated by cAMP hydrolysis in cerebral vessels. In addition, vasorelaxation modulated by PDE IV is compromised in chronic cerebral vasospasm associated with subarachnoid hemorrhage.
机译:在犬的基底动脉中,在体内和体外研究了IV型磷酸二酯酶同工酶(PDE IV)在调节脑血管张力中的作用。通过二乙基氨基乙醇(DEAE)-琼脂糖亲和色谱法分离从犬基底动脉提取的PDE同工酶,并根据对同工酶选择性PDE抑制剂的敏感性进行鉴定。在一个主要和一个次要的活性峰中观察到[3H] cAMP水解。加入cGMP(25%),西瓜唑丹(26%),咯利普兰(39%)以及siguazodan和咯利普兰的组合(95%)抑制了主要峰。选择性PDE IV抑制剂BRL 61063,咯利普兰和denbufylline是从犬基底动脉分离的PDE IV介导的[3H] -ccAMP水解的等效抑制剂[产生50%抑制的浓度(IC50S)= 0.21 +/- 0.05 microM,0.67 + /-0.23 microM和0.73 +/- 0.16 microM]。在预收缩的犬基底动脉环段中,选择性的PDE IV抑制剂产生了有效且完全的松弛(IC50S <150 nM)。相反,zaprinast(一种选择性PDE V抑制剂)和siguazodan(一种选择性PDE III抑制剂)仅产生了基底动脉的微弱松弛(分别为IC50S = 4.5 microM和> 10 microM)。通过去除内皮,1-NAME或腺苷受体拮抗作用,不会改变PDE IV抑制剂产生的血管舒张作用。在急性脑血管痉挛的犬模型中,所有三种选择性PDE IV抑制剂均可逆转自体血液产生的基底动脉痉挛,而不会改变平均动脉血压。相反,在两个慢性脑血管痉挛性出血犬模型中,长时间使用BRL 61063进行治疗未能改变基底性痉挛的发展。从慢性血管痉挛模型获得的基底动脉中,丹布西林诱导的体外松弛也明显受损。总之,PDE IV似乎是调节脑血管cAMP水解介导的血管紧张度的主要同工酶。另外,由PDE IV调节的血管舒张在与蛛网膜下腔出血相关的慢性脑血管痉挛中受损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号